hPSC gene editing for cardiac disease therapy.

Area of Science:

• Biomedical Research
• Stem Cell Biology
• Genetics

Background:

• Cardiovascular diseases (CVDs) are a major global cause of death.
• Studying CVD mechanisms is hindered by the limited availability of human cardiomyocytes with suitable genetic backgrounds.
• Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) offer a valuable model for CVD research.

Purpose of the Study:

• To review the application of genome-editing techniques in human pluripotent stem cells (hPSCs) for studying cardiovascular diseases.
• To highlight recent advancements in genome editing for hPSCs and their impact on cardiac disease research and therapy.

Main Methods:

• Utilizing genome-editing systems such as zinc finger nucleases, transcription activator-like effector nucleases, and CRISPR/Cas9 to modify hPSCs.
• Employing hPSC-CMs as a model system for investigating disease mechanisms.
• Focusing on advancements in genome editing efficiency within hPSCs.

Main Results:

• Genome-editing technologies have been successfully applied to hPSCs for CVD research.
• Specific genome-editing tools like CRISPR/Cas9 have shown significant promise.
• These advancements enhance the efficiency of cell-based studies for cardiac diseases.

Conclusions:

• Genome editing in hPSCs is a powerful tool for understanding cardiovascular diseases.
• hPSC-CMs combined with genome editing accelerate the study of cardiac disease mechanisms.
• This approach holds potential for developing novel therapies for cardiac conditions.